Shore Capital Reaffirms House Stock Rating for Oxford BioDynamics (LON:OBD)

Oxford BioDynamics (LON:OBDGet Free Report)‘s stock had its “house stock” rating restated by equities research analysts at Shore Capital in a note issued to investors on Tuesday, LSE.Co.UK reports.

Oxford BioDynamics Trading Up 3.6 %

LON OBD traded up GBX 0.29 ($0.00) during mid-day trading on Tuesday, reaching GBX 8.28 ($0.11). 1,983,643 shares of the stock were exchanged, compared to its average volume of 781,872. The stock has a market capitalization of £25.82 million, a PE ratio of -118.27 and a beta of 0.46. The company has a debt-to-equity ratio of 106.34, a quick ratio of 2.80 and a current ratio of 1.79. Oxford BioDynamics has a 1-year low of GBX 7.50 ($0.10) and a 1-year high of GBX 52 ($0.67). The business’s fifty day simple moving average is GBX 8.41 and its 200 day simple moving average is GBX 16.37.

About Oxford BioDynamics

(Get Free Report)

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.

Read More

Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.